Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 12:11 AM ET

Pharmaceuticals

Company Overview of Elcelyx Therapeutics, Inc.

Company Overview

Elcelyx Therapeutics, Inc. develops new therapies and re-positions existing therapies to meet serious unmet needs. Its development portfolio includes Metformin DR, a delayed-release formulation of metformin that releases metformin primarily in the distal small intestine and restricts metformin to the bowel primarily suited for patients who cannot use metformin owing to contraindications or poor tolerability. The company’s Metformin DR solution serves as an initial agent for the treatment of type 2 diabetes. The company was incorporated in 2009 and is headquartered in San Diego, California.

11975 El Camino Real

Suite 305

San Diego, CA 92130

United States

Founded in 2009

Phone:

858-876-1814

Fax:

858-509-4165

Key Executives for Elcelyx Therapeutics, Inc.

Chief Executive Officer, President, Member of Management Board and Director
Age: 61
Senior Vice President of Finance & Operations
Age: 68
Senior Vice President of R&D
Vice President of Regulatory Affairs & Quality Assurance
Compensation as of Fiscal Year 2015.

Elcelyx Therapeutics, Inc. Key Developments

Elcelyx Therapeutics Appoints Liang Tsui to the Board

Elcelyx has appointed Mr. Liang Tsui to the board of directors, joining current board members Ralph 'Chris' Christoffersen, Ph.D. (chairman), Rick Barry, Jim Glasheen, Ph.D., Ginger L. Graham, and Dr. Baron.

Elcelyx Therapeutics, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015

Elcelyx Therapeutics, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 . Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States.

Elcelyx Therapeutics, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 10:55 AM

Elcelyx Therapeutics, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 10:55 AM. Venue: Apella, 450 East 29th Street, New York, New York, United States. Speakers: Mark C. Wiggins, Senior Vice President of Business Development.

Similar Private Companies By Industry

Company Name Region
Onset Dermatologics LLC United States
Suneva Medical, Inc. United States
Mt. Cook Pharma, Inc. United States
Vitaline Corporation United States
EvoGenix, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 25, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Elcelyx Therapeutics, Inc., please visit elcelyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.